Tumor resistance to ferroptosis, which is driven by SCD1 in cancer cells or by fatty acid binding protein-4 (FABP4) in the tumor microenvironment, promotes tumor recurrence (Luis et al. 2021). Here, FABP4 is linked to cancer.